These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 18613460)

  • 1. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
    Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
    Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
    Manojlovic N; Nikolic L; Pilcevic D; Josifovski J; Babic D
    Hepatogastroenterology; 2004; 51(55):282-4. PubMed ID: 15011886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
    Atalay C; Atalay G; Altinok M
    Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
    Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
    J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
    Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.
    Ren Z; Borody T; Pang G; Li LC; Dunkley M; Clancy R
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1338-43. PubMed ID: 16105118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
    Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
    Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
    Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T
    FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
    Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.